ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 258625 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 258625; 2) Community: the network communities that were significantly associated with the response to NSC 258625; 3) Molecule: the relationships between components within communities and NSC 258625; 4) MDR: the compounds that were significantly associated with the NSC 258625.

NSC Compound Enrichment Correlation
NSC 736780 (2Z,4E)-2-cyano-5-[4-(diethylamino)phenyl]penta-2,4-dienethi oamide 0.0105972823829604 0.45947574
NSC 744989 7-methoxy-8-[(5-2-methoxy-4-[(E)-3-(2,4-dimethyl-3-quinolyl)-3-oxo-1-propenyl]phenoxybutyl)oxy]-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0105972823829604 0.19394029
NSC 757350 Thiothixene (USAN) 0.0105972823829604 0.18107598
NSC 762008 Copper(II) complex with a thiosemicarbazone as a ligand 0.0105972823829604 0.30460842
NSC 255104 Des-O-methylgeldanamycin 0.0108954273764103 0.45891962
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 0.0108954273764103 -0.058726635
NSC 292206 RUSTAIYAN A 0.0108954273764103 0.55435355
NSC 29443 Null 0.0108954273764103 0.48759214
NSC 607281 Null 0.0108954273764103 0.60397575
NSC 619961 Primaquine diphosphate 0.0108954273764103 0.13193857
Total:91  Current:30    [First] [Prev] [Next] [Last]